Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines

被引:26
作者
Fujimura, S
Suzumiya, J
Anzai, K
Ohkubo, K
Hata, T
Yamada, Y
Kamihira, S
Kikuchi, M
Ono, J
机构
[1] Fukuoka Univ, Sch Med, Dept Lab Med, Jonan Ku, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Sch Med, Dept Pathol, Jonan Ku, Fukuoka 8140180, Japan
[3] Nagasaki Univ, Sch Med, Inst Atom Dis, Dept Hematol, Nagasaki 852, Japan
[4] Nagasaki Univ, Sch Med, Dept Lab Med, Nagasaki 852, Japan
关键词
retinoic acid; ATL cell line; cell growth; cell cycle; apoptosis; CDK inhibitor;
D O I
10.1016/S0145-2126(98)00049-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adult T-cell leukemia (ATL) is a peripheral T-cell neoplasm caused by human T-cell leukemia virus type I (HTLV-I). Despite the administration of combined intensive chemotherapy, the reported survival time of patients with acute and lymphoma types of ATL is less than 10 months. We therefore examine the effects of all-trans-retinoic acid (ATRA), 9-cis-RA and 13-cis-RA and tried to elucidate the mechanisms of inducing growth inhibition and apoptosis by these RAs using four ATL cell lines established in our laboratory. All the investigated RAs inhibited cell growth and the cells were arrested at the G1 phase. Apoptosis was induced in three out of four cell lines. Among the growth regulatory proteins examined, the level of p21(Waf1/Cip1) protein was found to increase after RA treatment, thus resulting in pRb hypophosphorylation which also induced the arrest of the cells at the G1 phase. In addition, the p53 level decreased at the same time. Fas-FasL system and the downregulation of CD25 (IL-2R/alpha) expression did not seem to be involved. Based on these findings, the ability of RAs to induce a remission of ATL is thus strongly suggested. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:611 / 618
页数:8
相关论文
共 42 条
  • [1] Akagi T, 1996, ONCOGENE, V12, P1645
  • [2] Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins
    Beijersbergen, RL
    Bernards, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 103 - 120
  • [3] BISSONNETTE RP, 1995, MOL CELL BIOL, V15, P5576
  • [4] INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID
    BREITMAN, TR
    SELONICK, SE
    COLLINS, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05): : 2936 - 2940
  • [5] CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
    BRUNNER, T
    MOGIL, RJ
    LAFACE, D
    YOO, NJ
    MAHBOUBI, A
    ECHEVERRI, F
    MARTIN, SJ
    FORCE, WR
    LYNCH, DH
    WARE, CF
    GREEN, DR
    [J]. NATURE, 1995, 373 (6513) : 441 - 444
  • [6] P53 functional impairment and high p21(waf1/cip1) expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells
    Cereseto, A
    Diella, F
    Mulloy, JC
    Cara, A
    Michieli, P
    Grassmann, R
    Franchini, G
    Klotman, ME
    [J]. BLOOD, 1996, 88 (05) : 1551 - 1560
  • [7] AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95)
    DHEIN, J
    WALCZAK, H
    BAUMLER, C
    DEBATIN, KM
    KRAMMER, PH
    [J]. NATURE, 1995, 373 (6513) : 438 - 441
  • [8] Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with Adriamycin by using a p53-independent pathway
    Gartenhaus, RB
    Wang, P
    Hoffmann, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) : 265 - 268
  • [9] Gartenhaus RB, 1995, LEUKEMIA, V9, P2082
  • [10] Greene M. E., 1995, Gene Expression, V4, P281